Henry Schein, Inc. (HSIC)
| Market Cap | 11.34B |
| Revenue (ttm) | 10.62B |
| Net Income (ttm) | 439.53M |
| Shares Out | 142.30M |
| EPS (ttm) | 3.07 |
| PE Ratio | 27.02 |
| Forward PE | 21.65 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 10 |
| Last Price | $82.92 |
| Previous Close | $80.61 |
| Change ($) | 2.31 |
| Change (%) | 2.87% |
| Day's Open | 80.53 |
| Day's Range | 80.25 - 83.45 |
| Day's Volume | 528,196 |
| 52-Week Range | 49.83 - 83.45 |
Henry Schein (HSIC) is optimistic about maintaining robust sales of PPE and COVID-19-related products.
Henry Schein (HSIC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Henry Schein (HSIC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ...
Henry Schein Inc (NASDAQ: HSIC) raised its 2021 guidance after reporting first-quarter earnings, which topped the consensus. It posted an adjusted EPS of $1.24 ahead of the consensus of $0.85.
Henry Schein (HSIC) sees robust segmental performance in Q1 boosted by strong rebound in sales, and solid demand for PPE and COVID-19-related products.
Henry Schein (HSIC) delivered earnings and revenue surprises of 49.40% and 3.55%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Shares of Henry Schein (NASDAQ:HSIC) decreased 3.0% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 31.91% over the past year to $1.24, which ...
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. reports record first-quarter 2021 financial results from continuing operations.
HSIC vs. SAUHF: Which Stock Is the Better Value Option?
Henry Schein's (HSIC) PPE sales from its medical business are likely to have maintained the momentum. Also, global recovery trends of its dental business are expected to aid Q1 results.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to present at the Bank of America Securities 2021 virtual health care conference.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein CEO Stanley Bergman submits letter to congressional subcommittee supporting expanded COVID vaccine distribution.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to Webcast First Quarter 2021 Conference Call on Tuesday, May 4, 2021 at 10:00 A.M. Eastern Time
Here are a few MedTech stocks, Natus Medical (NTUS), Owens & Minor (OMI), ENDRA Life Sciences (NDRA), Penumbra (PEN), Apollo Medical (AMEH), which might be prudent investment choices now.
Henry Schein's (HSIC) recent majority ownership in Stradis Healthcare will advance the former's commitment to offer specialty solutions to customers.
Investors continue to be optimistic about Henry Schein (HSIC) on robust sales of PPE and COVID-19-related products.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. announced a majority investment in Stradis Medical, LLC to advance its commitment to the growing ambulatory surgery market.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced today its partnership with the Black Coalition Against COVID-19 (BCAC) in support of the BCAC's recent virtual town hall, “Ma...
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein CEO issues statement encouraging Biden-Harris Administration to include primary-care physicians in vaccine dissemination process.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Cares Foundation Launches Next Phase of the ‘Wearing is Caring' Campaign and Announces New Support for Special Olympics
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. announces reinstatement of share repurchase program.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has donated more than 10 milli...
NEW YORK--(BUSINESS WIRE)--Grin partners with Henry Schein Orthodontics and launches remote consultations that enables asynchronous consults and enhanced visibility.
We think that Henry Schein currently is a better pick compared to Boston Scientific. HSIC stock trades at about 0.9x trailing Revenues, compared to around 5.5x for Boston Scientific.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. has been recognized by Ethisphere as one of the 2021 World's Most Ethical Companies.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. announced that it will virtually present at the 2021 Barclays Global Healthcare Conference on March 9, 2021.
Henry Schein Opens Customer Assistance Hotline in Response to Winter Storms Across the United States
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in the Southern, Mid-Atlantic, and Northeastern states that the Henry Schein Customer Assistance Hotline is open ...
The dental equipment market seems ready to grow as it continues to recover from the COVID-19 pandemic slump, making it prudent to look at names like Henry Schein (HSIC) and McKesson (MCK)
Henry Schein (HSIC) sees robust segmental performance in Q4 boosted by strong rebound in sales, and solid demand for PPE and COVID-19-related products.
Henry Schein CEO on how to make the U.S. vaccine rollout more efficient
Medical supply distributor Henry Schein has a unique view on the pandemic and the recovery. Henry Schein CEO Stanley Bergman joined "Squawk Box" on Wednesday to give his insight on the vaccine rollout i...
Henry Schein (HSIC) delivered earnings and revenue surprises of 4.17% and 10.70%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Henry Schein (NASDAQ:HSIC) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share were up 3.09% year over year to $1.00, which beat the estimate of $0.99.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. reports fourth quarter 2020 financial results from continuing operations.
Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Henry Schein's (HSIC) medical business' PPE sales are likely to have maintained its momentum along with global recovery trends of the dental business during Q4.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. announced that Mohamad Ali and Deborah Derby have been appointed as members of the Company's Board of Directors.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. to webcast fourth quarter and full-year 2020 conference call on Wednesday, February 17, 2021.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. has been named to the FORTUNE® “World's Most Admired Companies” list for 2021, the 20th consecutive year it has been so honored.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Earns Top Marks In Human Rights Campaign's 2021 Corporate Equality Index
Here are some dirt-cheap MedTech value stocks which are expected to provide long-term gains in 2021.
The developments are expected to strengthen Henry Schein's (HSIC) presence in high potential and still-untapped markets.
Henry Schein Acquires Majority Interest in Prism Medical Products, Enters Home Medical Supply Market
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. acquires majority interest in Prism Medical Products and enters the home medical supply market.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. completes joint venture with Casa Schmidt to offer an expanded array of products and services to customers in Spain and Portugal.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. will virtually present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 7:30 a.m. Eastern time.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc., today announced the availability of Ansell Healthcare Product's AlphaTec® Model 214 gowns to pract...
About HSIC
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives... [Read more...]
| Industry Medical Distribution | IPO Date Nov 3, 1995 |
| CEO Stanley Bergman | Employees 19,000 |
| Stock Exchange NASDAQ | Ticker Symbol HSIC |
Financial Performance
In 2020, Henry Schein's revenue was $10.12 billion, an increase of 1.34% compared to the previous year's $9.99 billion. Earnings were $403.79 million, a decrease of -41.88%.
Analyst Forecasts
According to 17 analysts, the average rating for Henry Schein stock is "Buy." The 12-month stock price forecast is 80.29, which is a decrease of -3.17% from the latest price.